[Soluble adhesion molecules in antiphospholipid syndrome associated with systemic lupus erythematosus and in primary antiphospholipid syndrome].
OBJECTIVE
To evaluate clinical implications of measurements of the level of soluble cell molecules of adhesion (sCMA) in systemic lupus erythematosus (SLE) with antiphospholipid syndrome (APS) and primary APS (PAPS).


METHODS
Serum levels of sP-selectine, sE-selectine, sVCAM-1 were determined with enzyme immunoassay (R&D, USA) in 23 SLE with APS, 15 SLE patients free of APS and 19 patients with PAPS.


RESULTS
Mean levels of sE-selectine and sVCAM-1 in SLE patients with APS, PAPS and SLE was higher than in donors. Elevated mean levels of sP-selectine were observed only in SLE patients free of APS. These patients also showed a correlation between sVCAM-1 level and the disease activity (p < 0.01).


CONCLUSIONS
The development of immunopathological process in APS is associated with increased concentration of sCMA.
Aleksandrova
E N
EN
Novikov
A A
AA
Reshetniak
T M
TM
Kliukvina
N G
NG
Reshetniak
D V
DV
Samsonov
M Iu
MIu
Nasonov
E L
EL
D000328:Adult; D016736:Antiphospholipid Syndrome / Q000097:blood* / Q000209:etiology; D015815:Cell Adhesion Molecules / Q000097:blood*; D019040:E-Selectin / Q000097:blood; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D008180:Lupus Erythematosus, Systemic / Q000097:blood* / Q000150:complications; D008297:Male; D008875:Middle Aged; D019007:P-Selectin / Q000097:blood; D012995:Solubility
D015815:Cell Adhesion Molecules; D019040:E-Selectin; D019007:P-Selectin